Analysis by Toby C. “Chad” Frost, PharmD, JD, CPBS

A PBM audit is an enterprise-risk event—not a pharmacy-desk problem.

The strongest audit response begins with disciplined reconstruction, not argument. Leadership must connect claims, purchasing, inventory, contracts, compliance, and cash-flow exposure before deciding what the record proves.

Published August 4, 2026 • PBM audits, reimbursement, compliance, and enterprise risk

PBM audit letters arrive as reimbursement disputes. Executives should read them as enterprise-risk notices.

A single audit can implicate claims adjudication, prescription records, drug purchasing, inventory movement, provider-manual duties, accreditation standards, network participation, regulatory reporting, and liquidity. When those functions operate in separate silos, an explainable transaction can look unsupported—and a correctable process gap can become a material recoupment.

The first leadership mistake is assigning the response to one department. The second is drafting a narrative before reconstructing the evidence. A persuasive explanation cannot repair an incomplete transaction record.

The audit is really four reconciliations

  1. The claim trail: what was submitted, rejected, reversed, corrected, rebilled, paid, or adjusted.
  2. The product trail: what was purchased, received, transferred, dispensed, returned, or held in inventory.
  3. The authorization trail: what the prescription, prescriber communication, patient record, and dispensing documentation support.
  4. The obligation trail: what the governing agreement, provider manual, amendment, network rule, and applicable compliance standard required at the relevant time.

Those trails must be reconciled at the transaction level. Aggregate summaries can identify patterns, but they can also conceal reversals, rebills, timing differences, labeler changes, supplier omissions, and arithmetic errors. Executive decisions should rest on the underlying record, not merely the auditor’s characterization of it.

A practical executive-response model

1. Establish accountable ownership

Designate one leader with authority to coordinate operations, compliance, finance, contracting, information systems, and counsel. Every allegation should have an owner, an evidence source, a financial amount, a deadline, and a current disposition.

2. Preserve before interpreting

Secure native claim histories, prescriptions, invoices, inventory reports, correspondence, portal notices, contracts, manuals, and accreditation records. Preserve both the evidence and its source. Re-created spreadsheets are useful working tools, but they should not replace the underlying business records.

3. Build a line-item allegation matrix

Separate unsupported assertions from confirmed discrepancies. Record the billed claim, audit theory, relevant contract term, supporting or contradictory evidence, maximum exposure, responsible owner, and resolution status. This converts an intimidating demand into a governable body of work.

4. Quantify exposure before choosing the message

Leadership needs more than the demand total. Identify duplicated amounts, mathematical inconsistencies, documentation-only issues, transaction-level exceptions, systemic control failures, and defensible claims. That analysis determines reserves, escalation, response priorities, and operating consequences.

5. Repair the process while defending the record

An audit response should run on two tracks: establish what the existing evidence proves, and correct any operating weakness the review exposes. The response team should not quietly rewrite history; it should transparently distinguish contemporaneous evidence from later remediation.

Turn recoupment pressure into operating intelligence

A well-governed audit can reveal recurring reversal patterns, weak invoice ingestion, inconsistent prescription documentation, outdated provider-manual controls, credentialing gaps, training needs, or reimbursement terms that no longer support the business model. The value is not merely reducing a demand. It is preventing the next one and improving the reliability of the enterprise.

This is where pharmacy operations, executive accountability, and legal discipline must work together. My experience across PBM participation, claims, reimbursement, audits, recoupments, compliance, accreditation, and evidence-intensive regulatory matters has reinforced one rule: facts become defensible only when the organization can retrieve, reconcile, and explain them.

Applied scholarship strengthens that operating judgment by testing assumptions against current law, market structure, and evidence. The objective remains practical: give decision-makers a record they can trust and a response they can execute.